- DNLI Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
-
Shorts
Denali Therapeutics (DNLI) Short Interest
Company Profile
Filed | Period | Fund Series | #Shares | $Value | %Fund |
---|---|---|---|---|---|
22 Nov 24 | Sep 2024 | AGF U.S. Market Neutral Anti-Beta Fund | -71,060 | -2.07 mm | -0.50 |
27 Sep 24 | Jul 2024 | Saba Capital Income & Opportunities Fund | -556 | -13.55 k | -0.00 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.